文献速递神经介入DSACTMR

Neqstent辅助弹簧圈栓塞的大样本单中心短期随访经验

Large Single-Center Experience with Short-Term Follow-up of Neqstent-Assisted Coiling.
PubMed 文献 · AJNR Am J Neuroradiol · 2024-05-09

该单中心回顾性分析纳入2020年11月至2023年1月接受Neqstent辅助弹簧圈栓塞的20例颅内动脉瘤患者(9例未破裂、11例破裂性蛛网膜下腔出血)。术后即刻18/20(90%)达改良Raymond-Roy分级1级完全闭塞,6个月随访16/17(94.1%)保持充分闭塞;2例出现术后即刻并发症,1例6个月时残留神经功能缺损(mRS=2)。作者认为Neqstent治疗复杂宽颈动脉瘤短期结果有前景,但本队列初始并发症率相对较高,可能与器械释放的学习曲线及抗血小板药物使用有关。

要点

  • 术后即刻18/20(90%)达改良Raymond-Roy分级1级完全闭塞。
  • 6个月随访16/17(94.1%)保持充分闭塞(改良Raymond-Roy分级1级和2级)。
  • 2例出现术后即刻并发症,1例6个月时残留神经功能缺损(mRS=2)。

核心结论

  • 作者认为Neqstent治疗复杂宽颈动脉瘤的短期结果有前景,但本队列初始并发症率相对较高,可能与器械释放的学习经验及抗血小板药物使用有关。

研究设计与样本

  • 单中心回顾性分析,纳入2020年11月至2023年1月接受Neqstent辅助弹簧圈栓塞的破裂和未破裂颅内动脉瘤患者20例(9例未破裂、11例破裂性蛛网膜下腔出血);主要影像学结局在DSA、CTA或MRA上采用改良Raymond-Roy分级量化。

诊断标准与关键数值

  • 影像学结局以改良Raymond-Roy分级定义:即刻完全闭塞为改良Raymond-Roy分级1级,6个月随访完全闭塞为改良Raymond-Roy分级1级、充分闭塞为改良Raymond-Roy分级1级和2级。

临床应用与阅片要点

  • 作者认为Neqstent治疗复杂宽颈动脉瘤的短期结果有前景;本队列初始并发症率相对较高,可能与器械释放的学习经验及抗血小板药物使用有关。

局限性

  • 本队列初始并发症率相对较高,作者认为可能与器械释放的学习经验及抗血小板药物使用有关。
  • 作者称Neqstent治疗复杂宽颈动脉瘤的短期结果有前景,属短期随访结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Endovascular treatment of wide-neck bifurcation aneurysms has historically proved difficult with variable outcomes. Different endovascular techniques such as balloon-assisted coiling, stent-assisted coiling, or intrasaccular devices provide a varied range of efficacy and safety. Neqstent-assisted coiling is a new device and technique that aim to provide a maximum of both. We analyzed the early clinical and radiologic outcomes after the use of this new technique and device in our practice.

MATERIALS AND METHODS: This study was a retrospective analysis of ruptured and unruptured intracranial aneurysms treated with the Neqstent. The primary radiologic outcomes were quantified on DSA, CTA, or MRA using the modified Raymond-Roy criteria. The outcomes were defined as immediate complete occlusion (modified Raymond-Roy criteria 1) and complete (modified Raymond-Roy criteria 1) and adequate occlusion (modified Raymond-Roy criteria 1 and modified Raymond-Roy criteria 2) at 6 months posttreatment. The primary safety outcome was the rate of device-related adverse events. Secondary safety outcomes included time to discharge and change in the mRS score at 6-month follow-up.

RESULTS: Twenty patients were treated with the Neqstent from November 2020 to January 2023. Nine had unruptured aneurysms, and 11 were patients with subarachnoid haemorrhage due to ruptured aneurysms. Eighteen of 20 aneurysms (90%) treated demonstrated complete occlusion (modified Raymond-Roy criteria 1) on immediate postembolization angiograms. Sixteen of 17 aneurysms treated (94.1%) remained adequately occluded on 6-month follow-up (modified Raymond-Roy criteria 1 and modified Raymond-Roy criteria 2). Immediate postoperative complications occurred in 2 patients; only 1 patient had residual neurologic deficits at 6 months (mRS = 2).

CONCLUSIONS: Management of large, wide-neck aneurysms remains difficult, with high rates of recurrence and complications. The use of the Neqstent shows promising short-term results for the treatment of complex wide-neck aneurysms. Initial complication rates for our cohort were relatively high. However, this result is likely related to the initial learning experience of device deployment and the use of antiplatelets.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Islim FI, Saleem N, Patankar T, et al. Large Single-Center Experience with Short-Term Follow-up of Neqstent-Assisted Coiling. AJNR Am J Neuroradiol. 2024. PMID: 38514090. doi:10.3174/ajnr.A8187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。